BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 18621573)

  • 1. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach: chemical relational databases, and the role of the ISSCAN database on assessing chemical carcinogenicity.
    Benigni R; Bossa C; Richard AM; Yang C
    Ann Ist Super Sanita; 2008; 44(1):48-56. PubMed ID: 18469376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the OECD (Q)SAR Application Toolbox and Toxtree for predicting and profiling the carcinogenic potential of chemicals.
    Mombelli E; Devillers J
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):731-52. PubMed ID: 21120759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural alerts for estimating the carcinogenicity of pesticides and biocides.
    Devillers J; Mombelli E; Samsera R
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):89-106. PubMed ID: 21391143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software.
    Matthews EJ; Contrera JF
    Regul Toxicol Pharmacol; 1998 Dec; 28(3):242-64. PubMed ID: 10049796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computerized connectivity approach for analyzing the structural basis of mutagenicity in Salmonella and its relationship with rodent carcinogenicity.
    Perrotta A; Malacarne D; Taningher M; Pesenti R; Paolucci M; Parodi S
    Environ Mol Mutagen; 1996; 28(1):31-50. PubMed ID: 8698045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity and mechanistic relationships: the effect of chemical overlap on structural overlap in data bases of varying size and composition.
    Liu M; Sussman N; Klopman G; Rosenkranz HS
    Mutat Res; 1996 Nov; 372(1):79-85. PubMed ID: 9003534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity, carcinogenicity, and other end points.
    Benigni R; Battistelli CL; Bossa C; Colafranceschi M; Tcheremenskaia O
    Methods Mol Biol; 2013; 930():67-98. PubMed ID: 23086838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of criteria used to access carcinogenicity in CPANN QSAR models versus the knowledge-based expert system Toxtree.
    Fjodorova N; Novič M
    SAR QSAR Environ Res; 2014; 25(6):423-41. PubMed ID: 24716754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives in toxicological information management, and the role of ISSTOX databases in assessing chemical mutagenicity and carcinogenicity.
    Benigni R; Battistelli CL; Bossa C; Tcheremenskaia O; Crettaz P
    Mutagenesis; 2013 Jul; 28(4):401-9. PubMed ID: 23470317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico assessment of chemical mutagenesis in comparison with results of Salmonella microsome assay on 909 chemicals.
    Hayashi M; Kamata E; Hirose A; Takahashi M; Morita T; Ema M
    Mutat Res; 2005 Dec; 588(2):129-35. PubMed ID: 16257575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.